This compound is a pharmaceutical intermediate used in the manufacturing of abiraterone-related substances. It features a complex polycyclic structure with multiple ester and ether groups, primarily serving as a synthetic building block in laboratory and research settings.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 186826-68-6
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Acetato de abiraterona
active pharmaceutical ingredient
(3?)-16-[(3?)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone dimer impurity
Ambroxol EP Impurity B
Pharmaceutical intermediate for ambroxol
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
pharmaceutical intermediate
2-(2-cyanophenyl)acetic acid
Pharmaceutical intermediate
2-Methyl-3-nitropyridine
pharmaceutical intermediate
[(3S,8R,9S,10R,13S,14S)-17-[(3S,8R,9S,10R,13S,14S)-3-acetyloxy-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-16-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
LFPGBQAWACWPBR-NBDAZIKLSA-N
CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=C([C@]6(CC[C@H]7[C@H]([C@@H]6C5)CC=C8[C@@]7(CC[C@@H](C8)OC(=O)C)C)C)C9=CN=CC=C9)C)C
—